<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">RASBURICASE</span><br/>(ras-bur'i-case)<br/><span class="topboxtradename">Elitek, Fasturtec <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">antigout agent</span>; <span class="classification">antimetabolite</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1.5 mg/vial powder for injection</p>
<h1><a name="action">Actions</a></h1>
<p>A recombinant urate-oxidase enzyme produced by DNA technology from <i>Aspergillus flavus</i>. In humans, uric acid is the final step in the catabolic pathway of purines. Rasburicase catalyzes enzymatic oxidation of
         uric acid, thus it is only active at the end of the purine catabolic pathway.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Used to manage plasma uric acid levels in pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are
         receiving anti-cancer therapy that results in tumor lysis, and therefore elevates plasma uric acid.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Initial management of increased uric acid levels secondary to tumor lysis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Deficiency in glucose-6-phosphate dehydrogenase (G6PD); history of anaphylaxis or hypersensitivity reactions; hypersensitivity
         to rasburicase; hemolytic reactions or methemoglobinemia reactions to rasburicase; pregnancy (category C), lactation, children
         
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Patients at risk for G6PD deficiency (e.g., African or Mediterranean ancestry). Safety and efficacy in adults and elderly
         are unknown.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hyperuricemia</span><br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> <i>&gt;1 mo</i>, 0.150.2 mg/kg once/d <small>x</small> 5 d starting 424 h before chemotherapy<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span>  Reconstitute each 1.5 mg vial of ELITEK with 1 mL of the provided diluent and mix by swirling very gently. <b>Do not shake.</b> Discard if particulate matter is visible or if product is discolored after reconstitution. Remove the predetermined dose
                  from the reconstituted vials and inject enough NS into an infusion bag to achieve a final total volume of 50 mL.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> IV Infusion:</span>  Give over 30 min. <b>DO NOT GIVE BOLUS DOSE.</b> Infuse through an <b>unfiltered</b> line used for no other medications. If a separate line is not possible, flush the line with at least 15 mL of saline solution
                  before/after infusion of rasburicase.  
               </p>
</td>
</tr>
</table>
<ul>
<li>Immediately discontinue IV infusion and institute emergency measures for S&amp;S of anaphylaxis including chest pain, dyspnea,
            hypotension, and/or urticaria.
         </li>
</ul>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/</span><span class="incompattype">additive/</span><span class="incompattype">Y-site:</span> Do not mix or infuse with other drugs. 
      </p>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> <span class="speceff-common">Fever,</span> sepsis, severe hypersensitivity reactions including anaphylaxis at any time during treatment. <span class="typehead">CNS:</span> <span class="speceff-common">Headache.</span> <span class="typehead">GI:</span> <span class="speceff-common">Mucositis, vomiting, nausea, diarrhea, abdominal pain</span>. <span class="typehead">Hematologic:</span> Neutropenia. <span class="typehead">Skin:</span> <span class="speceff-common">Rash.</span>
<h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May give false elevations for <span class="alt">uric acid</span> if blood sample is left at room temperature.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Half-Life:</span> 18 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Patients at higher risk for G6PD deficiency (e.g., patients of African or Mediterranean ancestry) should be screened
            prior to starting therapy as this deficiency is a contraindication for this drug.
         </li>
<li>Lab test special instructions: Blood for uric acid anaylsis must be collected into prechilled tubes containing heparin anticoagulant
            and <b>immediately immersed in an ice water bath.</b> Plasma samples must be prepared by centrifugation in a precooled centrifuge (4° C) and plasma must be maintained in
            an ice water bath and analyzed for uric acid within 4 h of collection.
         </li>
<li>Monitor closely for S&amp;S of hypersensitivity and be prepared to institute emergency measures for anaphylaxis.</li>
<li>Monitor cardiovascular, respiratory, neurologic, and renal status throughout therapy.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report immediately any distressing S&amp;S to physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>